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Dissection of the precise contribution of
RNA transcripts versus genomic DNA
sequences is important for functional
assessment of long noncoding RNAs.
Here, Shen and colleagues demonstrate
discrete and opposing roles for the
lncRNA transcript Haunt and its genomic
locus in regulating the HOXA gene cluster
during embryonic stem cell
differentiation.Accession NumbersGSE58514
Cell Stem Cell
ArticleOpposing Roles for the lncRNA Haunt and Its
Genomic Locus in Regulating HOXA Gene Activation
during Embryonic Stem Cell Differentiation
Yafei Yin,1,2 Pixi Yan,1 Jinlong Lu,1 Guang Song,3 Yangyang Zhu,1 Zhaohui Li,1 Yi Zhao,1,4 Bin Shen,5 Xingxu Huang,5
Heng Zhu,3 Stuart H. Orkin,6,7 and Xiaohua Shen1,*
1Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing 100084, China
2School of Life Sciences, Peking University, Beijing 100871, China
3Department of Pharmacology and Molecular Sciences and the HiT Center, Johns Hopkins University School of Medicine, Baltimore,
MD 21205, USA
4Bioinformatics Research Group, Institute of Computing Technology, Chinese Academy of Sciences, Beijing 100190, China
5MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center of Nanjing University, National Resource Center for
Mutant Mice, Nanjing, Jiangsu 210061, China
6Division of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children’s Hospital, Howard Hughes Medical Institute,
Boston, MA 02115, USA
7Harvard Medical School, Boston, MA 02115, USA
*Correspondence: xshen@tsinghua.edu.cn
http://dx.doi.org/10.1016/j.stem.2015.03.007SUMMARY
Long noncoding RNAs (lncRNAs) have been impli-
cated in controlling various aspects of embryonic
stem cell (ESC) biology, although the functions of
specific lncRNAs, and the molecular mechanisms
through which they act, remain unclear. Here, we
demonstrate discrete and opposing roles for the
lncRNA transcript Haunt and its genomic locus in
regulating the HOXA gene cluster during ESC differ-
entiation. Reducing or enhancing Haunt expression,
with minimal disruption of the Haunt locus, led to
upregulation or downregulation of HOXA genes,
respectively. In contrast, increasingly large genomic
deletions within the Haunt locus attenuated HOXA
activation. The Haunt DNA locus contains potential
enhancers of HOXA activation, whereas Haunt RNA
acts to prevent aberrant HOXA expression. This
work reveals a multifaceted model of lncRNA-medi-
ated transcriptional regulation of the HOXA cluster,
with distinct roles for a lncRNA transcript and its
genomic locus, while illustrating the power of rapid
CRISPR/Cas9-based genome editing for assigning
lncRNA functions.
INTRODUCTION
Genome-wide transcriptome analyses have identified thou-
sands of long noncoding RNAs (lncRNAs) (Djebali et al., 2012;
Morris and Mattick, 2014; Ulitsky and Bartel, 2013). LncRNAs
are more than 200 nucleotides in length, transcribed by RNA po-
lymerase II, 50 capped, spliced, and polyadenylated; however,
they lack protein-coding potential. Despite their poor conserva-
tion and low levels of expression compared with protein-coding504 Cell Stem Cell 16, 504–516, May 7, 2015 ª2015 Elsevier Inc.genes, lncRNAs often exhibit cell- or tissue-specific expression
patterns, suggesting that considerable transcriptional regulation
underlies their expression (Ponting et al., 2009). Recent studies
have indicated that lncRNAs may serve as versatile regulators
of diverse aspects of biology in physiological and pathological
contexts, including imprinting, dosage compensation, differenti-
ation, development, and cancer (Batista and Chang, 2013; Sau-
vageau et al., 2013). Models suggest that lncRNAs might func-
tion at multiple levels, including transcription, mRNA splicing
and stability, translation, and chromatin and protein conforma-
tion (Guttman and Rinn, 2012; Wang and Chang, 2011). How-
ever, to date, few lncRNAs have been functionally characterized,
and their biological roles remain to be established.
Embryonic stem cells (ESCs) have the remarkable ability to
self-renew indefinitely in culture and to differentiate into all three
germ layers (Shen et al., 2009). LncRNAs are present in the
regulatory networks that contribute to reprogramming, ESC
self-renewal, and differentiation (Hu et al., 2012). For example,
the depletion of lincRNA-RoR impairs the formation of human
induced pluripotent stem cells, whereas its overexpression leads
to a moderate increase (2.5-fold) in cellular reprogramming
(Loewer et al., 2010). In addition, two RNAi screens revealed
many intergenic lncRNAs (lincRNAs) that are involved in
ESC function. One study showed that knocking down 26 out
of 147 lincRNAs, including linc1399 (CRNDE) and Haunt
(linc1547, linc-Hoxa1, Gm15055, or Halr1), resulted in moder-
ately decreased pluripotency marker gene expression (<50%)
(Guttman et al., 2011; Maamar et al., 2013; Sauvageau et al.,
2013). Another genome-scale shRNA screen of 1,280 lincRNAs
in mouse ESCs revealed 20 lincRNAs that are involved in the
maintenance of pluripotency (Lin et al., 2014), including lincRNA
TUNA, named as Megamind in zebrafish (Ulitsky et al., 2011),
which is also required for the neural differentiation of mouse
ESCs and for neurological function in zebrafish. However, there
is no overlap in the lincRNAs identified in the two studies.
RNAi has been extensively used to study lncRNA function (Hu
et al., 2012). The approach is limited by confounding off-target
effects and the inherent incompleteness of knockdown. Because
of their low-level expression and nuclear localization, lncRNAs
may be less efficiently knocked down compared with protein-
coding genes. In addition, subtle phenotypic differences are
often observed upon lncRNA depletion. It might be difficult to
distinguish bona fide biological effects from those caused by
technical variation across experiments. In viewof the advantages
of gene knockouts for the establishment of gene function
(Mattick, 2013), we have investigated the targeted deletion of
lncRNAs as an alternative approach.
Clustered, regularly interspaced short palindromic repeats
(CRISPRs) and CRISPR-associated (Cas) systems protect Bac-
teria and Archaea from invading viruses and plasmids (Wieden-
heft et al., 2012). Recently, the CRISPR/Cas9 systemwas adapt-
ed for RNA-guided genome editing to create gene knockout or
knockin animals, as well as cell lines, in multiple eukaryotic spe-
cies (Canver et al., 2014; Sander and Joung, 2014). Single-guide
RNAs (sgRNAs) induce Cas9 to create DNA double-strand
breaks (DSBs) at specific genomic loci. The repair of Cas9-
induced DSBs results in small deletions (<20 bp), tiny insertions,
and/or substitutions in the target sequence (Wang et al., 2014).
The CRISPR/Cas9 system has been widely used to inactivate
protein-coding genes by generating frameshift and nonsense
mutations. However, discrete interruptions in sequences are
unlikely to disrupt lncRNA functions unless they target the func-
tional sequences or domains within the lncRNA. Therefore, frag-
ment deletion may be the preferred approach for inactivation of
lncRNA transcription and/or function.
On the other hand, genomic deletion can simultaneously
remove important regulatory elements, thus confounding the
interpretation of whether a knockout phenotype is due to the
interruption of the lncRNA transcripts, the transcription itself,
or the DNA locus. Knockin approaches to inhibit or enhance
lncRNA expression without the deletion of potential regulatory
DNA should be employed to dissect the precise contribution of
RNA versus DNA when assigning lncRNA function.
In this study, we used Haunt as a paradigm to rigorously
investigate lncRNA functions and revealed a critical role of
Haunt in orchestrating HOXA activation and ESC differentiation
induced by retinoic acid (RA). We utilized CRISPR/Cas9 to
generate a series of mutant ESCs with genomic deletions
ranging from 0.1 to 140 kb in length in the Haunt and HOXA
loci. The successive truncations of Haunt DNA sequences
resulted in attenuated activation of HOXA genes during RA-
induced ESC differentiation. The severity of HOXA downregula-
tion scales with the genomic span of the deleted region. In
experimental contexts with minimal disruption of genomic se-
quences, reduced or excessive levels of Haunt transcripts
caused up- or downregulation of HOXA genes, respectively. In
addition, Haunt cDNA knockin failed to ‘‘rescue’’ the deletion
phenotype. These results demonstrated distinct roles for Haunt
RNA versus Haunt DNA in fine-tuning HOXA expression. We
further revealed that the Haunt DNA locus contains potential en-
hancers that interact with HOXA loci on chromatin and are
required for HOXA activation. On the other hand, Haunt RNAs
directly bind to chromatin and attenuate enhancer-promoter
contacts, thereby inhibiting HOXA activation. Our results
demonstrate that the transcripts and DNA sequence of a
lncRNA gene can have opposite roles in gene regulation andillustrate the power of rapid knockout and knockin by
CRISPR/Cas9 for assigning lncRNA functions.
RESULTS
Characterization of Haunt, a lncRNA Enriched in ESCs
ESCs provide an excellent in vitro model to systematically
examine the regulation and involvement of lncRNAs in cellular
differentiation during development (Shen et al., 2008). To com-
prehensively identify lncRNAs participating in ESC pluripotency
and lineage differentiation, we performed RNA-seq analyses of
mouse ESCs at multiple time points throughout differentiation
triggered by withdrawal of leukemia inhibitory factor (LIF) (Fig-
ures 1A, 1B, S1A, and S1B). In addition, we isolated ESC-derived
mesendodermal cells (ME;marked by brachyury (T)-driven GFP),
neural progenitor cells (NPCs; marked by Sox1-driven GFP), and
neural stem cells (NSCs) (Figure S1C) (Fehling et al., 2003; Shen
et al., 2008; Ying et al., 2003). Among the 645 differentially ex-
pressed lncRNAs (with FPKM > 1 and a fold change > 2
compared with that in ESCs), we identified 83 lncRNAs that
are enriched in ESCs (Figure 1B; Table S1). To assign ESC-spe-
cific functions to lncRNAs, we used lncRNA Haunt as a
paradigm.
The Haunt (HOXA upstream noncoding transcript) gene is
located 40 kb upstream of the HOXA cluster (Figure S1D).
Haunt is highly expressed in ESCs as well as in neural lineages
including NPCs and NSCs; however, it is not detectable in ME
cells, and its expression in ESCs is quickly downregulated
upon LIF withdrawal (Figure 1C; Table S1). Haunt has at least
five isoforms (Figure S1D), including an3.3-kb major transcript
(Figure 1C). Interestingly, the promoter sequence of Haunt is
more conserved than that of the gene body across species
(Figure S1D). The genomic locus is bound by multiple pluripo-
tency regulators, including OCT4, NANOG, and SOX2, and is en-
riched in epigenetic marks related to enhancer functions (p300,
H3K4me1, and DNase I hypersensitivity sites) and an active tran-
scription status (H3K4me3 and H3K36me3) in ESCs (Rivera and
Ren, 2013; Whyte et al., 2013). The loss of Haunt expression on
day 6 of LIF withdrawal is accompanied by an epigenetic switch
from active H3K4me3 and H3K36me3 marks to repressive
H3K27me3 marks at the Haunt genomic locus (Figure S1D).
Thus, Haunt transcription appears to be tightly regulated by
cell-specific transcription factors and epigenetic mechanisms.
It was reported that the depletion ofHaunt (previously referred
to as linc1547 and linc-Hoxa1) with shRNA or antisense oligos
(ASO) led to the downregulation of Oct4 and Nanog (Guttman
et al., 2011) and the upregulation of Hoxa1 (Maamar et al.,
2013). Despite appreciable knockdown of Haunt (70%–80%),
we failed to detect consistent expression changes in Nanog,
Oct4, and Hoxa1 in both CJ7 and E14tg ESCs (Figure 1D),
suggesting that Haunt expression is dispensable for the mainte-
nance of self-renewal and the repression of Hoxa1 in undifferen-
tiated ESCs.
CRISPR-Mediated Genomic Deletion in the Haunt Locus
Technical variation and incomplete knockdown by RNAi may
lead to subtle or inconsistent changes in gene expression. To
circumvent these problems, we utilized the CRISPR/Cas9 sys-






B Figure 1. CRISPR-Mediated Knockout of
the Haunt Locus
(A) Schematic diagram of ESC differentiation and
RNA-seq analysis.
(B) Heat map of FPKM values of lncRNAs enriched
in ESCs and lineage-committed cells. Here, we
show 83 genes enriched in ESCs (D0); 130, 134,
and 65 genes at days 2, 4, and 6 of ESC differen-
tiation induced by LIF withdrawal (D2, D4, and D6,
respectively); 65 in mesendoderm (ME) cells; 72 in
neural progenitor cells (NPCs); and 122 in neural
stem cells (NSCs). See also Table S1A.
(C) Northern blot analysis showing a major Haunt
transcript.
(D) RT-qPCR analysis of Haunt RNAi. CTL repre-
sents the scrambled shRNA control. n = 4,
including 2 shRNAs and 2 technical replicates.
**p < 0.01.
(E) Schematic diagram of knockout strategies at
the Haunt and HOXA loci. Haunt exons (E1–E3) are
shown in black boxes. A targeting vector for Haunt
58kb KO is shown at the bottom. P1 and P2 are
Southern blot probes.
(F) Validation of knockout ESC lines by PCR and
Southern blotting analysis. Gel images from
representative clones (a–m) are shown. CTL, an
unrelated genomic amplicon; 50 and 30 HA, PCR to
detect homologous recombination at the 50 and 30
ends of the homology arms; WT, wild-type allele;
KO, knockout allele.
(G) RT-qPCR analysis ofHaunt in knockouts. ‘‘q1,’’
primers q1f/q1r; ‘‘q2,’’ q2f/q2r. n = 2 replicates.
In (D) and (G), data are shown as mean ± SD. See
also Figures S1 and S2 and Table S1.promoter sequences to block Haunt expression, a knockout
strategy designated ‘‘pKO,’’ by six sgRNAs designed for a
2.3-kb region surrounding the Haunt transcription start site
(TSS) (Figure 1E). In the four homozygous ESC lines isolated, a
total of eight alleles (A–H) with deletions ranging from 131 to
2,062 bp were identified (Figures 1F and S1E–S1G). Deletion
usually occurred in the nearby sequences rather than at the pre-
cise target sites of the sgRNAs. In addition, sequence insertion
or reversion also occurred, which is consistent with the occur-
rence of imperfect nonhomologous end joining and repair.
Because of the complex and heterogeneous deletion patterns
generated by multiple sgRNAs, we sought to use a pair of506 Cell Stem Cell 16, 504–516, May 7, 2015 ª2015 Elsevier Inc.sgRNAs to generate deletions (Zhou
et al., 2014). Through the rational design
of sgRNAs in genomic regions with
increased chromatin accessibility and
prolonged drug selection for transfected
cells, we were able to effectively generate
a series of deletions by two sgRNAs (Fig-
ure S2A; Table 1).
To maximize the opportunity for the
complete inactivation of Haunt expres-
sion, we utilized a knockout strategy
designated Haunt ‘‘P-exon2 KO’’ (Fig-
ure 1E) to delete a 7.3-kb fragment
covering the promoter and the first twoexons of Haunt, which may contain regulatory elements as
inferred from transcription factor binding and DNase I hyper-
sensitivity mapping (Figure S1D). In addition, we used two
sgRNAs to delete exon 3, which accounts for 90% of the
entire Haunt transcript (‘‘exon3 KO’’) (Figure 1E). Nine clones
(19% efficiency) for P-exon2 KO and eight (17%) for exon3
KO carried biallelic deletions (Figure 1F; Figure S2B; Table
1). Off-target effects of CRISPR/Cas9 are considered far lower
than those observed with RNAi (Sander and Joung, 2014).
Nevertheless, consistent phenotypes from independent clones
minimize nonspecific and technical variations due to off-
targeting.
Table 1. Summary of the Efficiencies of CRISPR/Cas9-Induced Knockout and Knockin
















Haunt promoter (pKO) <2.3 6 – 24 1 4 21 17
promoter to exon 2 7.3 2 – 48 24 9 69 19
exon 3 7.9 2 – 48 ND 8 ND 17
28 kb upstream to 17 kb
downstream of Haunt
58 2 yes 85 6 3 11 4
43pA KI after TSS – 1 yes 96 ND 2 ND 2
CAG KI at TSS – 1 yes 96 ND 2 ND 2
promoter to intron 2 (P-Inr2) 10.4 2 yes 96 ND 5 ND 5
P-lnr2/CAG-cDNA KI 10.4 2 yes 96 ND 3 ND 3
HOXA HOXA cluster 140 2 – 127 20 3 18 2
HR, homologous recombination; Hete, heterozygote; Homo, homozygote; ND, not determined by experiments. For the 43pA KI and CAG KI cells, 2%
of the clones were homozygous, with biallelic insertion of the knockin cassette. For the P-Inr2/CAG-cDNA KI cells, 3% of the clones were homozygous
for the deletion and carried a single-allele insertion of the CAG-cDNA replacement cassette. All others, except those mentioned above, showed dele-
tion efficiency.Next, we targeted a 58-kb region, covering the 29-kb up-
stream and 17-kb downstream regions of the Haunt gene, a
knockout strategy designated ‘‘58kb KO,’’ through homologous
recombination facilitated by CRISPR/Cas9 (Figure 1E). Among
three ESC clones with biallelic deletions (Table 1), only two car-
ried the replacement cassette in one allele (Figures 1F, S2C, and
S2D). This result is in accordance with other observations indi-
cating that homologous recombination is less efficient than
nonhomologous end joining (Sander and Joung, 2014).
The pKO ESCs showed dramatic downregulation (7% left) of
Haunt expression (Figure 1G), demonstrating that disruption of
the TSS and core promoter sequence is effective for attenuating
lncRNA transcription. Haunt expression is abolished in P-exon2
KO and 58kb KO ESCs, whereas 12% of transcripts remained
in Haunt exon3 KO ESCs (Figure 1G). Because exon3 KO cells
and wild-type ESCs showed similar levels of Haunt pre-RNAs
containing introns 1 and 2 (Figure S2E), the deletion of exon 3
might negatively affect RNA stability, but not transcription.
Nevertheless, the residual truncated transcripts in exon3 KO
cells comprised only 10% of Haunt RNA sequences.
Misregulation of HOXA Induction in Haunt Knockouts
Consistent with the RNAi results, knockout of Haunt by the
above four deletion strategies failed to alter the expression of
pluripotency markers (Nanog, Oct4, and Tcl1) and Hoxa1, as
well as that of other HOXA genes, in undifferentiated ESCs
(Figure S2F; data not shown). In addition, neither depletion nor
deletion of Haunt altered the expression of HOXA genes during
differentiation triggered by LIF withdrawal (data not shown). Un-
der this condition, Haunt transcripts were rapidly downregulated
and HOXA genes remained silenced (Table S1), implying the
need for a relevant biological context in which to assess Haunt
function.
RA is a well-characterized morphogen that regulates the
spatial and temporal activation of HOX genes in vivo and
in vitro (Boncinelli et al., 1991). Interestingly, the addition of RA
not only activated HOXA genes but also enhanced the expres-
sion of Haunt (Figure 2A). Haunt expression is rapidly increasedto the highest level at 12 hr after RA addition, whereas HOXA
genes show a delayed increase and reach their peak expression
on days 1 to 3. Genes positioned toward the 50 side of the HOXA
cluster (Hoxa1–Hoxa6) are activated maximally for 300- to
15,000-fold, HOXA genes (Hoxa7, Hoxa9, and Hoxa10) located
in the middle exhibit 50-fold to 200-fold increases, while
Hoxa11 and Hoxa13 positioned at the 30 end of the locus are up-
regulated merely 2- to 5-fold during RA-induced ESC differenti-
ation (Figure S3A).
Interestingly, three Haunt pKO mutant lines with shorter dele-
tions (131–993 bp) showedmoderate but consistent increases in
the expression of HOXA genes on day 1 of RA treatment (Fig-
ure 2B). Cells in which Haunt was depleted by RNAi showed
similar increases albeit with larger variation. In contrast, other
Haunt knockout ESCs with larger genomic deletions ranging
from 7.3 to 58 kb showed decreased HOXA expression upon
RA treatment (Figure 2C). The 58kb KO mutants, which have
the largest deletion among all themutants, exhibited the greatest
reduction in the expression of allHOXA genes with the exception
of Hoxa13, a gene positioned at the very 30 end of the HOXA
cluster.
Time-course analysis of RA treatment showed that the activa-
tion of HOXA genes, but not the Hoxb1 control, was significantly
enhanced inHaunt pKO cells but attenuated and delayed in 58kb
KO (Figures 2A and S3B). RNA-seq profiling further confirmed
that the activation of the entire HOXA cluster (except Hoxa13),
but not the HOXB, HOXC, or HOXD clusters, was specifically
affected in pKO and 58kb KO cells (p = 0.024 and 0.002, respec-
tively, by Fisher’s exact test) (Figure 2D; Table S2). These results
suggest a critical role for the Haunt RNA and DNA locus in the
transcriptional regulation of HOXA genes.
CRISPR-Mediated Knockin of a Transcription Stop
Signal in the Haunt Locus
As opposed to the attenuated expression of HOXA genes by
large-fragment deletions in the Haunt locus, depletion of Haunt
RNA transcripts by RNAi or promoter deletion enhanced HOXA




D Figure 2. Misregulation of HOXA Genes in
Haunt Loss-of-Function Mutants
(A) Time-course RT-qPCR analysis of RA treat-
ment in wild-type (WT) and Haunt 58kb KO ESCs.
n = 4, including 2 independent clones and 2 tech-
nical replicates.
(B and C) RT-qPCR analysis of HOXA genes in
Haunt knockdown (B) and knockout (C) ESCs at
day 1 of RA treatment.
(D) Heat maps of FPKM values of Haunt and HOX
genes in day 2 and day 4 RA-treated ESCs. Genes
with FPKM > 2 in at least one sample are shown.
See also Table S2A.
(E) Schematic diagram of Haunt 43pA knockin.
(F) RT-qPCR analysis of HOXA genes in Haunt
43pA KI cells.
In (A)–(C) and (F), data are shown as mean ± SD.
n = 4 or 6, including 2 shRNAs for knockdown, 3
ESC clones (#a, c, and d) for pKO, 2 independent
clones for other knockouts, 3 independent clones
for 43pA KI, and 2 technical replicates per ESC
clone. *p < 0.05 and **p < 0.01. See also Figure S3
and Table S2.that large-fragment deletion may eliminate regulatory elements
embedded in the Haunt locus that are required for HOXA activa-
tion, whereas these sequences remain intact in RNAi and pKO
cells with shorter deletions.
To minimize the genetic influence of deletion, we sought to
inhibit lncRNA transcription or destabilize its RNA product by
introducing a transcription stop signal (Gutschner et al., 2011).
We knocked in a 43 polyA stop cassette immediately down-
stream of the TSS of Haunt, designated ‘‘43pA KI,’’ via homolo-
gous recombination facilitated by CRISPR/Cas9 (Figure 2E). The
homozygous insertion of a transcription stop cassette moder-
ately affected transcription and resulted in a 55% decrease
in Haunt transcripts (Figures 2F and S3C). Consistent with508 Cell Stem Cell 16, 504–516, May 7, 2015 ª2015 Elsevier Inc.RNAi and promoter deletion, Hoxa3 and
Hoxa5 were upregulated in 43pA KI cells
upon RA treatment (Figure 2F). These
results suggest that Haunt RNAs and/or
transcription may inhibitHOXA activation.
Constitutive cis Expression of
Haunt by CAG Knockin
To explore the role of Haunt RNA in the
regulation of HOXA genes, we examined
HOXA expression upon Haunt overex-
pression. Despite an 8-fold increase in
Haunt transcripts mediated by trans-
poson, no expression changes were eli-
cited in HOXA genes (Figure S3D). This
result provides evidence against a trans
function for Haunt in HOXA regulation.
To address cis effects, we knocked in
a strong constitutive promoter (CMV
early enhancer/chicken b actin [CAG] pro-
moter) immediately upstream of the TSS
of Haunt (designated ‘‘CAG KI’’) (Figures
3A and 3B). Cis overexpression of Hauntby 7-fold in ESCs led to the consistent downregulation of a set
of HOXA genes (Hoxa1 to Hoxa7 and Hoxa10) upon RA treat-
ment, demonstrating the inhibitory effect of Haunt RNA on
HOXA activation (Figures 3C, 3D, and S3E). This effect was
more specific to HOXA than to other HOX clusters (p = 0.005
by Fisher’s exact test), as shown by RNA-seq analysis of Haunt
CAG KI ESCs during the early phase of ESC differentiation (Fig-
ures 2D and S3E; Table S2).
To further dissect the function of lncRNA transcripts from that
of the embedded DNA sequence, we sought to introduce a
Haunt cDNA in place of the genomic locus. We deleted the re-
gion from the promoter to the end of intron 2 of Haunt (P-Inr2)






B C Figure 3. CRISPR-Mediated Knockin Anal-
ysis of Haunt Function
(A) Schematic diagram of CAG KI.
(B) Southern blotting analysis of Haunt CAG KI
cells.
(C) RT-qPCR analysis in Haunt CAG KI ESCs.
(D) RT-qPCR analysis of HOXA genes in Haunt
CAG KI cells at day 1 of RA treatment.
(E) Schematic diagram of Haunt P-Inr2 KO and P-
Inr2/CAG-cDNA KI cells. A region spanning from
the promoter to the end of intron 2 (P-Inr2) was
targeted to simultaneously establish deletion and
knockin alleles.
(F) Southern blotting analysis of representative
Haunt P-In2/CAG-cDNA KI and P-Inr2 KO ESCs.
WT, wild-type allele; CAG KI, CAG-cDNA knockin
allele; KO, allele with a deletion occurring at or near
the expected Cas9 cutting sites. Clone ‘‘a’’ of the
P-Inr2 KO ESCs contained an unknown mutation
and was thus excluded from the subsequent
analysis.
(G) RT-qPCR analysis ofHaunt andHOXA genes at
day 1 of RA treatment.
(H) Schematic summary of the effect of genetic
manipulation of the Haunt locus on HOXA induc-
tion. The upper panel shows the relative location of
the Haunt and HOXA genes in the genome. Haunt
pKO cells exhibit enhanced activation, whereas all
other cells exhibit downregulated expression of
HOXA genes. Brown bars with double arrowheads
indicate relative deletion regions. Green arrows
indicate the knockin of a CAG promoter or a CAG-
cDNA. Means of fold changes relative to the
expression in wild-type ESCs were plotted.
In (C), (D), and (G), data are shown as mean ± SD.
(n = 4, including 2 independent clones and 2
technical replicates.) *p < 0.05 and **p < 0.01. See
also Figure S3.expression cassette in this deleted region (Figures 3E and 3F).
ESC mutants, designated ‘‘P-Inr2/CAG-cDNA KI,’’ are homozy-
gous for the deletion and carry a one-allele insertion of the CAG-
cDNA cassette. For comparison, we also established ESCs with
a simple deletion of the same region (‘‘P-Inr2 KO’’). In P-Inr2 KO
cells, we found that Haunt expression was abolished, and HOXA
genes (Hoxa5 to Hoxa7) were downregulated (Figure 3G). This
result is similar to that observed in other Haunt knockouts with
large deletions. The Haunt expression level in P-Inr2/CAG-
cDNA KI ESCs was comparable (80%) to that in wild-type
ESCs. However, we did not observe ‘‘rescued’’ expression of
HOXA genes in these cells. Instead, P-Inr2/CAG-cDNA KI cells
showed more severe downregulation of HOXA genes (Hoxa1
to Hoxa9) compared with P-Inr2 KO cells with a straight deletion
(Figure 3G). Haunt cDNA replacement of genomic sequences
likely results in the additive effects of RNA-mediated repressionCell Stem Cell 16, 504and the loss of enhancer sequences.
Taken together (Figure 3H), these results
from knockouts and knockins demon-
strate that Haunt RNA and the DNA locus
have distinct roles in regulating HOXA
activation. Although Haunt RNA repre-
sses HOXA genes, the Haunt genomiclocus may contain regulatory DNA elements necessary for
HOXA induction.
Haunt DNA Interacts with the HOXA Region on
Chromatin
Studies of the transcriptional regulation ofHOXD genes revealed
that several enhancer-like sequences dispersed throughout
the nearby gene desert region, including one regulatory re-
gion located 50 kb upstream of the HOXD cluster, are in contact
with the HOXD gene locus through chromatin looping and may
quantitatively or qualitatively contribute to HOX gene transcrip-
tion in presumptive digits (Montavon et al., 2011). Putative RA-
response elements (RAREs) located upstream of the HOXA
and HOXB clusters were reported to exhibit enhancer activity
in transgenic mouse reporter assays (Nolte et al., 2013). We
found that two shadow enhancer regions identified previously–516, May 7, 2015 ª2015 Elsevier Inc. 509
AB
C
Figure 4. Haunt DNA Contains Enhancers
and Interacts with the HOXA Region on
Chromatin
(A) The Haunt DNA locus contains putative
enhancer sequences. Deletion regions are shown
at the top. * indicates anchor primers, and the
black arrow shows the direction of 3C primers
located upstream of each selected HindIII cutting
site. All sequencing tracks are from undifferenti-
ated (D0) or RA-treated ESCs, except for H3K27ac
ChIP-seq in RA-treated P19 embryonic carcinoma
cells. RARa-binding peaks are shown in vertical
bars at the bottom.
(B and C) 3C analysis of chromatin interactions
between the Haunt and HOXA loci. The y axis
shows the interaction frequency normalized to the
control BAC DNA and the nearest upstream site,
#27 in (B), #52 in (C). Data are shown as mean ±
SEM (n = 3, experimental replicates). The p values
between indicated samples in the region #6–14
(green shadow) are shown. Two additional 3C ex-
periments showed similar results (Figure S5).
See also Figure S5.(Nolte et al., 2013) are located downstream of the Haunt DNA
locus but inside of the deletion region of Haunt 58kb KO
(Figure S4A). In addition to nearby enhancer sequences identi-
fied previously, the Haunt DNA locus contains several RAREs
and DNase I hypersensitivity sites (Figure 4A). Moreover,
this region is strongly enriched in enhancer marks, including
p300, CTCF, SMC1, CBP, H3K27ac, H3K4me1, and H3K9ac.
Analysis of previously reported SMC1 and CTCF ChIA-PET da-
tasets revealed a few junction reads falling within the Haunt and
HOXA loci (Figure S4A) (Dowen et al., 2014; Handoko et al.,
2011).
To determine whether these regulatory sequences could func-
tion as HOXA enhancers, we performed chromatin conformation
capture (3C). In wild-type ESCs, we found that the Haunt and
HOXA loci were positioned in close proximity on chromatin,
and RA treatment slightly increased their interactions (Figures
4B, 4C, and S5), suggesting that the Haunt locus harbors poten-
tial HOXA enhancers. Interestingly, the interactions between the
Haunt and HOXA loci upon RA treatment were dramatically510 Cell Stem Cell 16, 504–516, May 7, 2015 ª2015 Elsevier Inc.increased in pKO cells depleted of Haunt
but were decreased in CAG KI cells
with excess Haunt transcripts (Figures
4B, 4C, and S5). Thus, Haunt RNA ap-
pears to inhibit chromatin looping and
the accessibility of HOXA enhancers
embedded in its DNA locus.
Haunt RNA Binds to the Chromatin
on HOXA Loci
Subcellular fractionation showed that
62% of Haunt transcripts are located in
the nucleus, and more than half appeared
to be bound to chromatin (Figure 5A). To
reveal the DNA targets, we performed
chromatin isolation by RNA purification
(ChIRP) of endogenous Haunt with anti-sense oligos tiled along the entire Haunt transcript sequence
(Chu et al., 2011). We usedHaunt P-exon2 KO cells as a negative
control in this assay (Figure 5B). We isolated and sequenced
both RNA and DNA fragments associated with the Haunt-con-
taining complex. In P-exon2 KO cells, no RNA reads were de-
tected at the Haunt gene locus, and there were very few DNA
reads at exon 3, demonstrating the specificity of RNA affinity
capture (Figures 5C and S6A). In wild-type ESCs, Haunt was
the primary RNA component identified by ChIRP followed by
RNA-seq.
In undifferentiated ESCs, ChIRP DNA-seq showed that Haunt
RNA coated a continuous 1-Mbp genomic region, with signals
concentrated between the Skap2 and HOXA cluster, which are
the nearest genes upstream and downstream of Haunt, respec-
tively (Figures 5C and S6B). The strongest binding signal was
observed in the Haunt gene body, with a bias toward the 30
end. The ChIRP signals decreased sharply downstream of the
Haunt locus in the vicinity of theHoxa1 gene andwere decreased





B Figure 5. Haunt RNA Binds toHOXA Loci on
Chromatin
(A) Subcellular fractionation of Haunt. Gapdh, U1,
and Xist RNAs serve as controls for the cytosolic,
nuclear, and chromatin fractions, respectively.
(B) Scheme illustrating chromatin isolation by RNA
purification (ChIRP) of Haunt.
(C) Deep sequencing tracks of Haunt ChIRP,
H3K27me3, and H3K4me3 ChIP in undifferenti-
ated (D0) and day 1 RA-treated (RA) ESCs. The
upper tracks show normalized read densities of
RNA-seq and DNA-seq following the ChIRP pro-
cedure. WT, wild-type ESCs; KO, P-exon2 KO as
the control for ChIRP (with the deletion region
shown at the top). The RNA-seq track of RA-
treated ESCs on day 1 is shown at the bottom.
(D) A zoomed-out view of Haunt ChIRP DNA-seq
signals in wild-type ESCs within a 1-Mb range of
the Haunt locus. The Haunt TSS is centered in the
middle (the red arrow). Normalization was per-
formed by dividing the number of actual reads in
each 10-kb bin by the sequencing depth. The
ChIRP DNA-seq tracks are shown at the bottom.
(E) Quantification of Haunt ChIRP DNA-seq signals
in the genomic regions of Haunt and nearby genes
in wild-type ESCs. The fold change between D0
and RA-treated ESCs is shown above the corre-
sponding gene.
(F) Quantification of H3K27me3 ChIP-seq signals
in regions of individual genes. Brackets indicate
genes with >1.8-fold change between RA-treated
wild-type and pKO cells.
(G) H3K27me3 ChIP-qPCR. The y axis shows fold
enrichment relative to the input and genomic
background (g-CS). Data are shown asmean ± SD.
(n = 3 biological replicates.)
In (E) and (F), the y axis shows normalized numbers
of reads that fall into the DNA locus of each gene,
covering the 1-kb region upstream and down-
stream of the gene body, to the sequencing depth
and the length of each gene region. See also Fig-
ures S6 and S7.Moreover, diminished chromatin binding of Haunt was accom-
panied by the appearance of a long stretch of repressive
H3K27me3 marks covering the entire HOXA region (105 kb in
length). In comparison, ChIRP signals extended beyond the
Skap2 locus in the upstream region of Haunt (Figure S6B). No
significant DNA peaks were detected beyond Haunt and its
nearby loci, supporting a cis function of Haunt on chromatin.
Interestingly, upon the addition of RA, more Haunt RNA
transcripts became associated with chromatin near the 50 side
of the HOXA region, with a peak at the Hoxa5 and Hoxa6 lociCell Stem Cell 16, 504(6- to 7-fold increase) (Figures 5C–5E). In
comparison, the levels of chromatin-
associated Haunt transcripts showed no
change at the far distal Hoxa13 site and
increased by only 2-fold at the Haunt
and Skap2 loci. Thus, rather than nonspe-
cific chromatin binding due to increased
expression upon RA treatment, the en-
hanced association of Haunt with the
HOXA DNA loci could be specificallyrelated to the function ofHaunt RNA. The strong and direct inter-
action of Haunt RNA with the 50 side of the HOXA cluster indi-
cates that Haunt has a direct role in modulating HOXA induction.
Coincidently, in the same genomic region (Hoxa1 to Hoxa6)
where enhanced chromatin association of Haunt RNA was
shown, the H3K27me3 levels decreased more dramatically in
pKO cells than in wild-type cells at day 1 of RA addition (Figures
5F, 5G, and S6C). The rapid removal of H3K27me3 is consistent
with upregulated HOXA expression in pKO cells. In comparison,
neither H3K4me3 binding in the HOXA region nor H3K27me3–516, May 7, 2015 ª2015 Elsevier Inc. 511
and H3K4me3 distributions at the Skap2 locus were affected in
pKO cells, regardless of RA addition (Figures 5F and S6D).
This result indicates that Haunt RNA specifically reshape the
H3K27me3 landscape at the HOXA loci during RA-induced
ESC differentiation.
Previous work suggested that PURB (purine-rich element
binding protein B) might facilitate Haunt function, causing inhibi-
tion of Hoxa1 transcription (Maamar et al., 2013). However, we
failed to observe significant changes in HOXA expression upon
the depletion of PURB, PURA, or both (Figure S7), which argues
against the direct involvement of PUR proteins in the effect of
Haunt on the HOXA cluster.
Haunt Orchestrates Proper ESC Differentiation
To assess the role of Haunt in ESC function, we analyzed the
gene expression of Haunt knockout and knockin ESCs by
RNA-seq and performed gene set enrichment analysis (GSEA)
on a predefined set of RA-induced genes that are upregulated
at day 4 after RA addition (Table S3). Haunt 58kb KO and CAG
KI ESCs, which have low or no HOXA expression, all exhibit
global downregulation of RA-induced genes (negative enrich-
ment score [NES] = 1.6 1.7, p < 105) compared with wild-
type cells (Figure 6A; Table S3). In contrast, Haunt pKO cells
with high-level expression of HOXA genes did not show signifi-
cant downregulation (NES = 0.9, p = 0.4) of RA-induced genes
by GSEA. In addition, gene ontology (GO) analysis of downregu-
lated genes in Haunt 58kb KO cells revealed significant enrich-
ment (>2-fold over the genomic background, p < 5 3 105) in
functional terms related to pattern specification, organ morpho-
genesis, and development (Figure 6B; Table S4), whereas no
functional terms were enriched in the upregulated genes (data
not shown). Moreover, many differentiation regulators, including
transcription factors and signaling proteins, failed to be activated
in 58kb KO and CAG KI cells to the full extent observed in wild-
type or pKO ESCs at day 4 of RA addition (Figure 6C; Table S2),
ruling out the potential bias driven by aberrant HOXA expression
in the above analyses.
To ask if these changes are dependent on HOXA expression,
we deleted a 140-kb region encoding the HOXA cluster in ESCs,
designated ‘‘HOXA KO’’ (Figures 1E, 1F, S2G, and S2H). HOXA
KO ESCs exhibit similar, strong downregulation of RA-induced
genes (NES = 1.9, p < 105) upon differentiation (Figures 6A–
6C). Attenuated activation of HOXA genes might negatively
impact the ESC differentiation program. This result indicates
that Haunt has a role in orchestrating ESC differentiation, and
this rolemay be partially exerted via the transcriptional regulation
of HOXA genes.
DISCUSSION
Loss-of-function approachesmediated by siRNA/shRNA or anti-
sense oligos are commonly used to assess the function of
lncRNAs (Hu et al., 2012). In contrast to previous reports (Gutt-
man et al., 2011; Maamar et al., 2013), we failed to detect consis-
tent changes in the expression of pluripotency markers and
Hoxa1 in undifferentiated ESCs when Haunt was depleted or
deleted. The prolonged culture time required to establish
knockout cell lines may result in some variability in gene expres-
sion due to adaptation to the deletion as opposed to the acute512 Cell Stem Cell 16, 504–516, May 7, 2015 ª2015 Elsevier Inc.depletion caused by RNAi. Nevertheless, these discrepancies
further reinforced the notion that apparent phenotypes observed
after RNAi knockdown should be confirmed by alternative ge-
netic approaches.
The targeted deletion or silencing of specific genes has been
considered the gold standard to reveal a gene’s function (Mat-
tick, 2013). However, genomic deletions may cause an indirect
effect due to removal of overlapping regulatory DNA elements,
confounding functional assignment of lncRNA genes. Here, we
simultaneously utilized complementary approaches, including
knockout versus knockin, deletion versus overexpression, and
knockdown versus cDNA rescue, and investigated the lncRNA
Haunt with rigor. We have demonstrated the complex effects
of Haunt RNA and its DNA sequences on the induction of
HOXA gene expression during RA-induced differentiation (Fig-
ure 6D). Our work illustrated the power of rapid knockout and
knockin by CRISPR/Cas9 for assigning the precise contribution
of RNA transcripts versus genomic DNA sequences of a lncRNA
gene.
The severity of HOXA misregulation following Haunt deletion
scales with the size of the deleted genomic region, arguing for
the successive removal of possible regulatory sequences. This
is supported by evidence that replacement of the genomic dele-
tion with Haunt cDNA in P-Inr2/CAG-cDNA KI cells failed to
‘‘rescue’’ the deletion phenotype despite restoration of Haunt
expression. Indeed, we showed that the Haunt gene locus con-
tains potential enhancers that interact with HOXA loci through
chromatin looping. These chromatin contacts were enhanced
in pKO cells but attenuated in CAG KI cells, further suggesting
that Haunt DNA sequences may contain functional enhancers
for HOXA. We concluded that the Haunt DNA locus activates
HOXA transcription when certain environmental signals are
received (Figure 6D).
When genomic sequences are minimally disrupted (knock-
down, pKO, 43pA KI, and CAG KI), reduced or excessive levels
of Haunt transcripts cause up- or downregulation of HOXA
genes, respectively. Although P-Inr2 KO and P-Inr2/CAG-
cDNA KI ESCs contain the same genomic deletions, P-Inr2/
CAG-cDNA KI cells, with relatively normal levels of Haunt tran-
scripts, exhibited more severe downregulation of HOXA genes
than P-Inr2 KO cells. Genetic approaches could not distinguish
whether these defects are due to lncRNA transcripts or tran-
scription per se, but the RNAi knockdown result indicates an
inhibitory role of Haunt RNA transcripts on HOXA expression
upon RA treatment. In addition, strong chromatin binding of
Haunt to the 50 side of the HOXA cluster upon RA treatment
demonstrated that the RNA transcripts have a direct role in
modulating the HOXA locus. Haunt RNA transcripts might
compete with Haunt DNA sequences for interaction with HOXA
sequences, resulting in attenuated enhancer-promoter contacts
between theHaunt andHOXA loci (Figure 6D). Therefore, excess
Haunt transcripts might serve as a ‘‘brake’’ to precisely control
the expression ofHOXA genes. Our work indicates that a lncRNA
and its genomic locus can have distinct functions in regulating
the same target genes.
DNA, which serves as the stable, highly structured, and
continuous carrier of genetic information, is relatively static and
rigidly positionedwithin chromatin. In contrast, RNA ismore flex-





Figure 6. Haunt Orchestrates Proper ESC Differentiation
(A) Gene set enrichment analysis (GSEA) profiles on day 4 of RA treatment. Compared with the wild-type ESCs, Haunt 58kb KO, CAG KI, and HOXA KO, but not
pKO, ESCs showed significant depletion or downregulation of RA-induced genes. NES, normalized enrichment scores. See also Table S3.
(B) Gene ontology (GO) analysis of genes that were downregulated inHOXA KO andHaunt 58kb KO ESCs compared with the wild-type on day 4 of RA treatment.
See also Table S4.
(C) Heat map of FPKM values of representative genes that are misregulated in various mutant ESCs on day 2 or day 4 of RA treatment. See also Table S2B.
(D) Amodel showing the complex effects ofHauntRNA/transcription and its DNA locus in fine-tuningHOXA expression and orchestrating ESC differentiation. The
Haunt DNA locus provides enhancers that are required for the activation of HOXA genes, whereas Haunt RNA transcripts attenuate long-range chromatin in-
teractions between theHaunt enhancer DNA and theHOXA region likely through its direct chromatin association. In addition,HauntRNA and/or transcriptionmay
reshape the H3K27me3 landscape at theHOXA loci during RA-induced ESC differentiation. Thus, in opposing the activating role ofHauntDNA sequences,Haunt
RNAs serve as a ‘‘brake’’ to prevent aberrant activation of HOXA genes. The fine balance between the active and repressive functions of Haunt DNA and RNA,
respectively, precisely controls the proper expression of the developmentally regulated HOXA locus and contributes to orchestrated differentiation of ESCs. See
also Tables S2, S3, and S4.information in a precise, controllable manner is through the
expression of RNA transcripts to regulate or counteract the
activity of the DNA locus that produces the transcripts. For
example, 30% enhancer sequences generate bidirectional
enhancer-associated RNAs (eRNAs), which in turn increase theactivity of the enhancer that encodes the RNA (Kim et al.,
2010; Lam et al., 2013; Li et al., 2013b;Melo et al., 2013;Mousavi
et al., 2013; Wang et al., 2011a). Our work suggests a two-faced
mechanism by which a lncRNA gene fine-tunes downstream
transcription through its DNA sequences and RNA transcripts.Cell Stem Cell 16, 504–516, May 7, 2015 ª2015 Elsevier Inc. 513
As many lncRNA gene loci may contain regulatory sequences
and overlap with protein-coding genes (Derrien et al., 2012; Dje-
bali et al., 2012), we propose that lncRNA transcripts may have
the flexibility to convey more subtle regulatory information car-
ried in the genome. Therefore, care is needed when assigning
a loss-of-function phenotype to lncRNA transcripts or to regula-
tory sequences in the genomic loci that encode.
Evolutionarily conserved, homeobox-containing HOX genes
regulate body patterning in all bilateria (Pearson et al., 2005),
and their misexpression can cause homeotic transformations.
Several lncRNAs, including HOTAIR, HOTTIP, HOTAIRM1, and
Mistral, have been shown to be involved in cis or trans regulation
of HOX genes (Bertani et al., 2011; Rinn et al., 2007; Wang et al.,
2011b; Zhang et al., 2009). We found that two lncRNA loci
located 50 kb upstream of the HOXC cluster may contain
similar HOXC enhancers (Figure S4B). Thus, Haunt and these
lncRNAs represent another layer of RNA regulation, together
with pleiotropic regulatory DNA elements, transcription factors,
and chromatin regulators, which contributes to the fine-tuning
of HOX expression throughout development. Further experi-
ments are required to understand the precise mechanism by
which Haunt RNA functions. Identification of proteins that
interact with Haunt may help to elucidate its functionality.
The HOXA cluster is marked by bivalent H3K27me3 and
H3K4me3modifications in ESCs, and the expression of this clus-
ter is spatiotemporally regulated during development (Bernstein
et al., 2005), whereas Skap2 is constitutively expressed (Table
S1). Chromatin coating of Haunt in undifferentiated ESCs ap-
pears to demarcate two chromatin domains containing constitu-
tively active or developmentally regulated genes. The normal
distributions of H3K27me3 and H3K4me3 marks at both the up-
stream Skap2 and downstream HOXA loci in undifferentiated
pKO mutant cells argue against a role for Haunt in preventing
the inappropriate spreading of these epigenetic marks in
ESCs. However, during establishment of the pluripotent state,
it is unclear whether Haunt transcription might promote an
open chromatin conformation to prime future activation of
HOXA genes upon RA signaling. Preexisting chromatin looping
of promoter-enhancer contacts has been shown to be a strong
predictor of gene induction upon TNF-a signaling in human fibro-
blasts (Jin et al., 2013). Consistent with their regulatory role, the
expression and increase ofHaunt transcripts precede the induc-
tion of HOXA genes upon RA treatment.
Despite being dispensable for the self-renewal of ESCs,Haunt
orchestrates proper activation of HOXA and early differentiation
genes during transiting from the pluripotency to a committed
cellular state. Many chromatin regulators, including Polycomb
group proteins and DNA methyltransferases, are critical for
ESC differentiation, but are not required for ESC self-renewal
(Shen et al., 2008, 2009; Surani et al., 2007). Therefore, the role
of lncRNA-mediated chromatin and transcriptional regulation in
lineage differentiation further highlights the importance of chro-
matin dynamics in cell-fate transitions.
Haunt knockout mice are born at a normal Mendelian ratio,
indicating a nonessential role in animal survival (Sauvageau
et al., 2013). However, the absence of both active DNA se-
quences and inhibitory RNA transcripts due to a simple deletion
might offset the functional effects ofHaunt, thus confounding the
phenotypic interpretation in vivo. On the other hand, viable514 Cell Stem Cell 16, 504–516, May 7, 2015 ª2015 Elsevier Inc.knockouts may show tissue-specific pathologies or problems.
Careful analysis of HOTAIR single knockout mice showed mild
skeletal defects in developing embryos as well as gene regulato-
ry phenotypes in both primary and cultured tail tip fibroblasts (Li
et al., 2013a); however, one report indicated that mice lacking
the HOXC cluster, including HOTAIR, exhibited no apparent
phenotype (Schorderet and Duboule, 2011). In another example,
mice lacking Evf2 lncRNA had normal survival rates but exhibited
a reduced numbers of GABAergic interneurons in the embryonic
brain and synaptic inhibition in the adult brain (Bond et al., 2009).
Thus, like many lncRNAs, Haunt may contribute to the fine-tun-
ing of genome management and transcription rather than acting
as a genetic switch per se. Facile and efficient manipulation of
genomic segments, as illustrated here, should help to elucidate
the subtle cis and trans regulatory roles of lncRNAs and the
embedded DNA sequences, leading to a fuller understanding
of the evolutionary and functional mechanisms of noncoding
portions of the genome.
EXPERIMENTAL PROCEDURES
Cell Culture, Haunt RNAi, and Overexpression
ESCs, ME, NPCs, and NSCs were cultured or derived as previously described
(Shen et al., 2008). Haunt RNAi or overexpression was mediated by PiggyBac.
Details are described in the Supplemental Information. The sequences of the
shRNAs are listed in Table S5.
CRISPR/Cas9-Mediated Knockout and Knockin
For knockouts, Cas9 and sgRNAs were cotransfected in ESCs (Shen et al.,
2013). For knockins, targeting vectors were cotransfected with plasmids ex-
pressing Cas9 and sgRNAs. ESC colonies were picked, expanded, and
analyzed to identify deletions or insertions. The 43 polyA transcription stop
cassette (43pA) comprises the 3 3 SV40 polyA signal sequence and a
BGH polyA signal, with a total of four polyA stop signals. For CAG KI, the
CAG promoter was inserted immediately upstream of the Haunt TSS.
For the CAG-cDNA knockin, the targeting vector was cotransfected with
Cas9 and two sgRNAs covering a section spanning from the promoter to
the end of intron 2 of Haunt in order to achieve simultaneous deletion and
replacement of the deleted region. Details are described in the Supplemental
Information.
Chromatin Isolation by RNA Purification
ChIRP was performed as previously described with modifications (Chu et al.,
2011). The 59-nt DNA biotinylated probes, more stringent crosslinking, and
wash conditions were employed. Details are described in the Supplemental
Information.
Chromosome Conformation Capture
The 3C analysis was performed as previously described (Miele and Dekker,
2009). Interaction frequencies were then calculated by dividing the normalized
ratios in the chromatin samples to the level in the BAC control (Bmq385 g10).
Details are described in the Supplemental Information.
Chromatin Immunoprecipitation, High-Throughput Sequencing, and
Data Analysis
ChIP was performed as previously described (Shen et al., 2008). The DNA
or RNA libraries were constructed by following Illumina library preparation
protocols. High-throughput sequencing was performed on a HiSeq2000 or
HiSeq2500. Raw reads were uniquely mapped to the mouse genome (mm9).
Details and published datasets used in this study are described in the Supple-
mental Information.
Quantitative RT-qPCR Analysis
Total RNA was reverse-transcribed using SuperScript III (Life Technologies).
Gene expression was normalized to GADPH, and fold changes were
calculated as described in the figure legends. Error bars in the RNA analysis
represent the SDs of the average fold changes based on at least two cell lines
and/or two experimental replicates as indicated in the figure legends. The
primer sequences are listed in Table S5.
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